BIO-TECHNE Corp Income Tax Expense
BIO-TECHNE Corp (TECH) reported Income Tax Expense of $58.82 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-24
- BIO-TECHNE Corp income tax expense (benefit) for the quarter ending 2026-06-30 was $16.06M.
- BIO-TECHNE Corp income tax expense (benefit) for the quarter ending 2026-03-31 was $20.18M, a 28.64% increase year-over-year.
- BIO-TECHNE Corp income tax expense (benefit) for the quarter ending 2025-12-31 was $12.78M, a 59.97% increase year-over-year.
- BIO-TECHNE Corp income tax expense (benefit) for the quarter ending 2025-09-30 was $9.81M, a 49.23% increase year-over-year.
- BIO-TECHNE Corp income tax expense (benefit) for fiscal 2026 was $58.82M, a 134.68% increase from fiscal 2025.
- BIO-TECHNE Corp income tax expense (benefit) for fiscal 2025 was $25.06M, a 42.53% increase from fiscal 2024.
- BIO-TECHNE Corp income tax expense (benefit) for fiscal 2024 was $17.58M, a 66.96% decline from fiscal 2023.
- BIO-TECHNE Corp income tax expense (benefit) for fiscal 2023 was $53.22M, a 38.99% increase from fiscal 2022.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 9 month as first filed | Income Tax Expense (Benefit) 12 month | Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $16.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $36.24M derived: sum of 2 quarters · filed 2026-08-24 | $49.01M derived: sum of 3 quarters · filed 2026-08-24 | $58.82M 10-K · filed 2026-08-24 | ||||
| 2026-03-31 | $20.18M 10-Q · filed 2026-05-06 | $32.95M derived: sum of 2 quarters · filed 2026-05-06 | $42.76M 10-Q · filed 2026-05-06 | $37.58M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-12-31 | $12.78M 10-Q · filed 2026-02-04 | $22.58M 10-Q · filed 2026-02-04 | $17.40M derived: sum of 3 quarters · filed 2026-08-24 | $33.09M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-09-30 | $9.81M 10-Q · filed 2025-11-05 | $4.63M derived: sum of 2 quarters · filed 2026-08-24 | $20.31M derived: sum of 3 quarters · filed 2026-08-24 | $28.30M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2025-06-30 | -$5.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $10.51M derived: sum of 2 quarters · filed 2026-08-24 | $18.49M derived: sum of 3 quarters · filed 2026-08-24 | $25.06M 10-K · filed 2026-08-24 | ||||
| 2025-03-31 | $15.69M 10-Q · filed 2026-05-06 | $23.67M derived: sum of 2 quarters · filed 2026-05-06 | $30.24M 10-Q · filed 2026-05-06 | $31.32M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-12-31 | $7.99M 10-Q · filed 2026-02-04 | $14.56M 10-Q · filed 2026-02-04 | $15.63M derived: sum of 3 quarters · filed 2026-08-24 | $27.66M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-09-30 | $6.57M 10-Q · filed 2025-11-05 | $7.64M derived: sum of 2 quarters · filed 2026-08-24 | $19.67M derived: sum of 3 quarters · filed 2026-08-24 | $25.59M derived: sum of 4 quarters · filed 2026-08-24 | ||||
| 2024-06-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-24 | $13.10M derived: sum of 2 quarters · filed 2026-08-24 | $19.02M derived: sum of 3 quarters · filed 2026-08-24 | $17.58M 10-K · filed 2026-08-24 | ||||
| 2024-03-31 | $12.03M 10-Q · filed 2025-05-08 | $17.95M derived: sum of 2 quarters · filed 2025-05-08 | $16.51M 10-Q · filed 2025-05-08 | $29.34M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-12-31 | $5.92M 10-Q · filed 2025-02-06 | $4.49M 10-Q · filed 2025-02-06 | $17.32M derived: sum of 3 quarters · filed 2025-08-22 | $27.30M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-09-30 | -$1.44M 10-Q · filed 2024-11-05 | $11.40M derived: sum of 2 quarters · filed 2025-08-22 | $21.38M derived: sum of 3 quarters · filed 2025-08-22 | $37.80M derived: sum of 4 quarters · filed 2025-08-22 | ||||
| 2023-06-30 | $12.83M derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-22 | $22.81M derived: sum of 2 quarters · filed 2025-08-22 | $39.23M derived: sum of 3 quarters · filed 2025-08-22 | $53.22M 10-K · filed 2025-08-22 | ||||
| 2023-03-31 | $9.98M 10-Q · filed 2024-05-06 | $26.40M derived: sum of 2 quarters · filed 2024-05-06 | $40.38M 10-Q · filed 2024-05-06 | $57.52M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-12-31 | $16.42M 10-Q · filed 2024-02-07 | $30.41M 10-Q · filed 2024-02-07 | $47.54M derived: sum of 3 quarters · filed 2024-08-22 | $56.17M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-09-30 | $13.98M 10-Q · filed 2023-11-07 | $31.12M derived: sum of 2 quarters · filed 2024-08-22 | $39.75M derived: sum of 3 quarters · filed 2024-08-22 | $53.87M derived: sum of 4 quarters · filed 2024-08-22 | ||||
| 2022-06-30 | $17.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-22 | $25.77M derived: sum of 2 quarters · filed 2024-08-22 | $39.88M derived: sum of 3 quarters · filed 2024-08-22 | $38.29M 10-K · filed 2024-08-22 | ||||
| 2022-03-31 | $8.63M 10-Q · filed 2023-05-08 | $22.75M derived: sum of 2 quarters · filed 2023-05-08 | $21.15M 10-Q · filed 2023-05-08 | $13.62M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-12-31 | $14.12M 10-Q · filed 2023-02-07 | $12.52M 10-Q · filed 2023-02-07 | $4.99M derived: sum of 3 quarters · filed 2023-08-23 | $4.94M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-09-30 | -$1.60M 10-Q · filed 2022-11-07 | -$9.13M derived: sum of 2 quarters · filed 2023-08-23 | -$9.18M derived: sum of 3 quarters · filed 2023-08-23 | $1.05M derived: sum of 4 quarters · filed 2023-08-23 | ||||
| 2021-06-30 | -$7.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-23 | -$7.58M derived: sum of 2 quarters · filed 2023-08-23 | $2.65M derived: sum of 3 quarters · filed 2023-08-23 | $8.59M 10-K · filed 2023-08-23 | ||||
| 2021-03-31 | -$48.00K 10-Q · filed 2022-05-09 | $10.18M derived: sum of 2 quarters · filed 2022-05-09 | $16.12M 10-Q · filed 2022-05-09 | $18.80M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-12-31 | $10.22M 10-Q · filed 2022-02-07 | $16.17M 10-Q · filed 2022-02-07 | $18.85M derived: sum of 3 quarters · filed 2022-08-24 | $29.24M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-09-30 | $5.94M 10-Q · filed 2021-11-08 | $8.62M derived: sum of 2 quarters · filed 2022-08-24 | $19.01M derived: sum of 3 quarters · filed 2022-08-24 | $49.72M derived: sum of 4 quarters · filed 2022-08-24 | ||||
| 2020-06-30 | $2.68M derived: 10-K 12 month − 10-Q 9 month · filed 2022-08-24 | $13.07M derived: sum of 2 quarters · filed 2022-08-24 | $43.77M derived: sum of 3 quarters · filed 2022-08-24 | $47.18M 10-K · filed 2022-08-24 | ||||
| 2020-03-31 | $10.39M 10-Q · filed 2021-05-07 | $41.09M derived: sum of 2 quarters · filed 2021-05-07 | $44.50M 10-Q · filed 2021-05-07 | $50.83M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-12-31 | $30.70M 10-Q · filed 2021-02-08 | $34.11M 10-Q · filed 2021-02-08 | $40.44M derived: sum of 3 quarters · filed 2021-08-25 | $45.66M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-09-30 | $3.41M 10-Q · filed 2020-11-09 | $9.73M derived: sum of 2 quarters · filed 2021-08-25 | $14.96M derived: sum of 3 quarters · filed 2021-08-25 | $19.17M derived: sum of 4 quarters · filed 2021-08-25 | ||||
| 2019-06-30 | $6.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-08-25 | $11.55M derived: sum of 2 quarters · filed 2021-08-25 | $15.76M derived: sum of 3 quarters · filed 2021-08-25 | $15.94M 10-K · filed 2021-08-25 | $15.94M 10-K · filed 2019-08-28 | |||
| 2019-03-31 | $5.22M 10-Q · filed 2020-05-11 | $9.43M derived: sum of 2 quarters · filed 2020-05-11 | $9.62M 10-Q · filed 2020-05-11 | $24.19M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-12-31 | $4.21M 10-Q · filed 2020-02-06 | $4.39M 10-Q · filed 2020-02-06 | $18.96M derived: sum of 3 quarters · filed 2020-08-26 | $24.21M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-09-30 | $183.00K 10-Q · filed 2019-11-06 | $14.75M derived: sum of 2 quarters · filed 2020-08-26 | $20.00M derived: sum of 3 quarters · filed 2020-08-26 | -$7.12M derived: sum of 4 quarters · filed 2020-08-26 | ||||
| 2018-06-30 | $14.57M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-26 | $19.81M derived: sum of 2 quarters · filed 2020-08-26 | -$7.30M derived: sum of 3 quarters · filed 2020-08-26 | -$198.00K 10-K · filed 2020-08-26 | ||||
| 2018-03-31 | $5.24M 10-Q · filed 2019-05-07 | -$21.87M derived: sum of 2 quarters · filed 2019-05-07 | -$14.77M 10-Q · filed 2019-05-07 | -$4.53M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-12-31 | -$27.12M 10-Q · filed 2019-02-07 | -$20.01M 10-Q · filed 2019-02-07 | -$9.77M derived: sum of 3 quarters · filed 2019-11-06 | -$800.00K derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-09-30 | $7.10M 10-Q · filed 2018-11-07 | $17.34M derived: sum of 2 quarters · filed 2019-11-06 | $26.32M derived: sum of 3 quarters · filed 2019-11-06 | $34.04M derived: sum of 4 quarters · filed 2019-11-06 | ||||
| 2017-06-30 | $10.24M derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-11-06 | $19.21M derived: sum of 2 quarters · filed 2019-11-06 | $26.93M derived: sum of 3 quarters · filed 2019-11-06 | $35.88M 10-K/A · filed 2019-11-06 | ||||
| 2017-03-31 | $8.97M 10-Q · filed 2018-05-09 | $8.64M 10-Q · filed 2017-05-10 | $16.70M derived: sum of 2 quarters · filed 2018-05-09 | $25.64M 10-Q · filed 2018-05-09 | $23.71M 10-Q · filed 2017-05-10 | $37.78M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-12-31 | $7.72M 10-Q · filed 2018-02-08 | $7.23M 10-Q · filed 2017-02-09 | $16.66M 10-Q · filed 2018-02-08 | $15.07M 10-Q · filed 2017-02-09 | $28.81M derived: sum of 3 quarters · filed 2018-08-27 | $41.01M derived: sum of 4 quarters · filed 2018-08-27 | ||
| 2016-09-30 | $8.94M 10-Q · filed 2017-11-09 | $7.84M 10-Q · filed 2016-11-09 | $21.09M derived: sum of 2 quarters · filed 2018-08-27 | $33.28M derived: sum of 3 quarters · filed 2018-08-27 | $42.81M derived: sum of 4 quarters · filed 2018-08-27 | |||
| 2016-06-30 | $12.14M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-27 | $24.34M derived: sum of 2 quarters · filed 2018-08-27 | $33.87M derived: sum of 3 quarters · filed 2018-08-27 | $43.01M 10-K · filed 2018-08-27 | ||||
| 2016-03-31 | $12.20M 10-Q · filed 2017-05-10 | $21.72M derived: sum of 2 quarters · filed 2017-05-10 | $30.86M 10-Q · filed 2017-05-10 | $42.77M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-12-31 | $9.52M 10-Q · filed 2017-02-09 | $18.66M 10-Q · filed 2017-02-09 | $30.57M derived: sum of 3 quarters · filed 2017-09-07 | $45.04M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-09-30 | $9.14M 10-Q · filed 2016-11-09 | $21.05M derived: sum of 2 quarters · filed 2017-09-07 | $35.52M derived: sum of 3 quarters · filed 2017-09-07 | $44.88M derived: sum of 4 quarters · filed 2017-09-07 | ||||
| 2015-06-30 | $11.91M derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-07 | $26.38M derived: sum of 2 quarters · filed 2017-09-07 | $35.74M derived: sum of 3 quarters · filed 2017-09-07 | $46.43M 10-K · filed 2017-09-07 | ||||
| 2015-03-31 | $14.47M 10-Q · filed 2016-05-10 | $23.82M derived: sum of 2 quarters · filed 2016-05-10 | $34.51M 10-Q · filed 2016-05-10 | $47.14M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-12-31 | $9.35M 10-Q · filed 2016-02-09 | $20.05M 10-Q · filed 2016-02-09 | $32.67M derived: sum of 3 quarters · filed 2016-08-29 | $47.10M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-09-30 | $10.69M 10-Q · filed 2015-11-09 | $23.32M derived: sum of 2 quarters · filed 2016-08-29 | $37.75M derived: sum of 3 quarters · filed 2016-08-29 | $48.91M derived: sum of 4 quarters · filed 2016-08-29 | ||||
| 2014-06-30 | $12.63M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-29 | $27.05M derived: sum of 2 quarters · filed 2016-08-29 | $38.22M derived: sum of 3 quarters · filed 2016-08-29 | $50.44M 10-K · filed 2016-08-29 | ||||
| 2014-03-31 | $14.43M 10-Q · filed 2015-05-11 | $25.59M derived: sum of 2 quarters · filed 2015-05-11 | $37.82M 10-Q · filed 2015-05-11 | $50.17M derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-12-31 | $11.16M 10-Q · filed 2015-02-09 | $23.39M 10-Q · filed 2015-02-09 | $35.74M derived: sum of 3 quarters · filed 2015-08-31 | $47.09M derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-09-30 | $12.23M 10-Q · filed 2014-11-10 | $24.58M derived: sum of 2 quarters · filed 2015-08-31 | $35.93M derived: sum of 3 quarters · filed 2015-08-31 | $48.01M derived: sum of 4 quarters · filed 2015-08-31 | ||||
| 2013-06-30 | $12.35M derived: 10-K 12 month − 10-Q 9 month · filed 2015-08-31 | $23.70M derived: sum of 2 quarters · filed 2015-08-31 | $35.78M derived: sum of 3 quarters · filed 2015-08-31 | $48.10M 10-K · filed 2015-08-31 | ||||
| 2013-03-31 | $11.35M 10-Q · filed 2014-05-12 | $23.43M derived: sum of 2 quarters · filed 2014-05-12 | $35.75M 10-Q · filed 2014-05-12 | $49.12M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-12-31 | $12.08M 10-Q · filed 2014-02-04 | $24.40M 10-Q · filed 2014-02-04 | $37.78M derived: sum of 3 quarters · filed 2014-08-29 | $49.23M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-09-30 | $12.32M 10-Q · filed 2013-11-12 | $25.69M derived: sum of 2 quarters · filed 2014-08-29 | $37.14M derived: sum of 3 quarters · filed 2014-08-29 | $49.20M derived: sum of 4 quarters · filed 2014-08-29 | ||||
| 2012-06-30 | $13.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-29 | $24.82M derived: sum of 2 quarters · filed 2014-08-29 | $36.88M derived: sum of 3 quarters · filed 2014-08-29 | $49.86M 10-K · filed 2014-08-29 | ||||
| 2012-03-31 | $11.45M 10-Q · filed 2013-05-10 | $23.51M derived: sum of 2 quarters · filed 2013-05-10 | $36.49M 10-Q · filed 2013-05-10 | $51.13M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-12-31 | $12.06M 10-Q · filed 2013-02-11 | $25.04M 10-Q · filed 2013-02-11 | $39.68M derived: sum of 3 quarters · filed 2013-08-29 | $54.00M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-09-30 | $12.98M 10-Q · filed 2012-11-09 | $27.62M derived: sum of 2 quarters · filed 2013-08-29 | $41.94M derived: sum of 3 quarters · filed 2013-08-29 | $53.08M derived: sum of 4 quarters · filed 2013-08-29 | ||||
| 2011-06-30 | $14.64M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-29 | $28.96M derived: sum of 2 quarters · filed 2013-08-29 | $40.10M derived: sum of 3 quarters · filed 2013-08-29 | $52.68M 10-K · filed 2013-08-29 | ||||
| 2011-03-31 | $14.32M 10-Q · filed 2012-05-10 | $25.46M derived: sum of 2 quarters · filed 2012-05-10 | $38.04M 10-Q · filed 2012-05-10 | $50.74M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-12-31 | $11.14M 10-Q · filed 2012-02-07 | $23.72M 10-Q · filed 2012-02-07 | $36.42M derived: sum of 3 quarters · filed 2012-08-29 | $45.48M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-09-30 | $12.58M 10-Q · filed 2011-11-09 | $25.29M derived: sum of 2 quarters · filed 2012-08-29 | $34.34M derived: sum of 3 quarters · filed 2012-08-29 | $46.31M derived: sum of 4 quarters · filed 2012-08-29 | ||||
| 2010-06-30 | $12.71M derived: 10-K 12 month − 10-Q 9 month · filed 2012-08-29 | $21.76M derived: sum of 2 quarters · filed 2012-08-29 | $33.73M derived: sum of 3 quarters · filed 2012-08-29 | $46.67M 10-K · filed 2012-08-29 | ||||
| 2010-03-31 | $9.05M 10-Q · filed 2011-05-10 | $21.03M derived: sum of 2 quarters · filed 2011-05-10 | $33.96M 10-Q · filed 2011-05-10 | |||||
| 2009-12-31 | $11.98M 10-Q · filed 2011-02-09 | $24.91M 10-Q · filed 2011-02-09 | ||||||
| 2009-09-30 | $12.94M 10-Q · filed 2010-11-09 | |||||||
| 2009-06-30 | $50.12M 10-K · filed 2011-08-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |